Exicure, Inc. (XCUR)
1.29
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 11:34
Exicure Research and Development Expense (Annual) : 3.286M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.286M |
| December 31, 2024 | 0.00 |
| December 31, 2023 | 0.048M |
| December 31, 2022 | 17.91M |
| December 31, 2021 | 46.58M |
| December 31, 2020 | 30.65M |
| Date | Value |
|---|---|
| December 31, 2019 | 19.34M |
| December 31, 2018 | 14.12M |
| December 31, 2017 | 13.08M |
| December 31, 2016 | 13.66M |
| December 31, 2015 | 10.12M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tenax Therapeutics, Inc. | 32.67M |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | 82.57M |
| Absci Corp. | 80.72M |
| Celularity, Inc. | 9.222M |